
Sign up to save your podcasts
Or


We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine
In Part 2 of the interview with Amy Dockser Marcus, Pulitzer Prize winning Wall Street Reporter and Author, she and host Meryl Comer discuss a rare disease often likened to Children’s Alzheimer’s. The common thread is advancing the science with new pathways for treating disease and conducting research. Amy talks about if this new collaborative research model aimed at saving children would work for elderly populations with long-term chronic diseases like Alzheimer’s. In the process to accelerate new drug development, science may be forever changed.
This episode is sponsored by Genentech and Eisai.
If you have recommendations for topics or guests, email us at [email protected]. To learn more go to: https://www.usagainstalzheimers.org/
Support the show
By Meryl Comer, UsAgainstAlzheimer's4.7
1414 ratings
We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine
In Part 2 of the interview with Amy Dockser Marcus, Pulitzer Prize winning Wall Street Reporter and Author, she and host Meryl Comer discuss a rare disease often likened to Children’s Alzheimer’s. The common thread is advancing the science with new pathways for treating disease and conducting research. Amy talks about if this new collaborative research model aimed at saving children would work for elderly populations with long-term chronic diseases like Alzheimer’s. In the process to accelerate new drug development, science may be forever changed.
This episode is sponsored by Genentech and Eisai.
If you have recommendations for topics or guests, email us at [email protected]. To learn more go to: https://www.usagainstalzheimers.org/
Support the show

91,297 Listeners

32,246 Listeners

37,247 Listeners

113,121 Listeners

47,718 Listeners

8,238 Listeners

16,525 Listeners